Article

jdsupra.com on 2018-01-23 01:00

Obviousness-Type Double Patenting Dangers in the U.S.

The Federal Circuit’s decision in Gilead Sciences, Inc. v. Natco Pharma Ltd. introduced even more confusion in an already confusing area of the law – ...

Dangers

Fox P.L.L.C.

JD Supra

Related news

[Audio] Podcast: Alissa Lipton and Jeffrey Jacobstein on Obviousness-Type Double Patenting jdsupra.com
Judge Grants Gilead Motion To Invalidate Remicade Patent For Obviousness-Type Double Patenting jdsupra.com
Massachusetts , Cranz
[Webinar] How Far Will Obviousness-Type Double Patenting Go: Considerations and Strategies - August 9th, 10:00 am China, CST jdsupra.com
China
Obviousness Versus Obviousness-Type Double Patenting jdsupra.com
Canton of Geneva , The District
Obviousness-Type Double Patenting: It’s Complicated jdsupra.com
California , United States , Switzerland
Patent Prosecution Tool Kit: Obviousness-Type Double Patenting jdsupra.com
Ingelheim am Rhein , Treasure Island , Breckenridge , Canton of Geneva , Longi
Federal Circuit Narrows Reach Of Obviousness-Type Double Patenting jdsupra.com
California , United States , Switzerland
Obviousness-Type Double Patenting is Alive and Well jdsupra.com
Exclusive License Can Raise Obviousness-Type Double Patenting Issues jdsupra.com
Same Applicant, Similar Claims Support Obviousness-Type Double Patenting Rejection jdsupra.com
Important New Decision Regarding Obviousness-Type Double Patenting Challenge Between Patents from the Same Family jdsupra.com
Michigan , New Jersey , The District , Siusi , Tanabe-shi
Recent Federal Circuit Decisions on Obviousness-Type Double Patenting May Shape Life Science Patent Portfolio Management jdsupra.com
California , United States , Switzerland
“All Substantial Rights” Test Informative in Obviousness-Type Double Patenting Context jdsupra.com
Federal Circuit: Patent Term Adjustment Results in Invalidity on Obviousness-Type Double Patenting Grounds jdsupra.com
Clarifying the Interplay of Patent Term Adjustment and Obviousness-Type Double Patenting: In Re Cellect jdsupra.com
United States , Amitsoq
A Second Look at the Innovation Act Obviousness Type Double Patenting Statute jdsupra.com
Americas , United States
Federal Circuit Partially Clarifies Obviousness-Type Double Patenting Law in Two Opinions Released the Same Day jdsupra.com
California , United States , Switzerland
Federal Circuit Protects Novartis Gilenya Patent From Obviousness-Type Double Patenting jdsupra.com
California , United States , Switzerland
Obviousness-Type Double Patenting Just Became Less of a Problem for Innovators jdsupra.com
California , United States , Switzerland
The End Is Not So Near: Patent Term Adjustments Count in Obviousness-Type Double Patenting Determinations jdsupra.com